4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-007023
Options or other derivatives
- Chief Scientific Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2023-02-01 | Grant or award · Employee Stock Option (Right to Buy) | +105,000 | 105,000 | D: show line 1 in the form | |||||
| Monahan Joseph Chief Scientific Officer | 2023-02-01 | Grant or award · Restricted Stock Units | +30,000 | 30,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…